DUBLIN--(BUSINESS WIRE)--The "Pulmonary Arterial Hypertension - Pipeline Insight, 2019" drug pipelines has been added to ResearchAndMarkets.com's offering.
Pulmonary Arterial Hypertension - Pipeline Insight, 2019 report offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Pulmonary Arterial Hypertension development.
The report provides detailed coverage of the pipeline landscape for this mechanism of action, equipped with data from multiple sources with complete pipeline analysis by developmental stage, associated indications, route of administration and molecule type.
Pipeline therapeutics development coverage provides descriptive product profiles including (but not limited to) drug description, product development and R&D activities encompassing clinical and pre-clinical studies, designations, collaborations, licensing deals, grants, technologies and patent details.
The report assesses the active Pulmonary Arterial Hypertension pipeline products by developmental stage, product type, molecule type, and administration route.
Key Topics Covered:
1. Report Introduction
2. Pulmonary Arterial Hypertension Overview
3. Pipeline Therapeutics
- An Overview of Pipeline Products for Pulmonary Arterial Hypertension
4. Comparative Analysis
5. Products in Clinical Stage
- Product Description
- Research and Development
- Product Development Activities
6. Products in Pre-Clinical and Discovery Stage
- Product Description
- Research and Development
- Product Development Activities
7. Therapeutic Assessment
- Assessment by Route of Administration
- Assessment by Stage and Route of Administration
- Assessment by Molecule Type
- Assessment by Stage and Molecule Type
8. Inactive Products
- Product Description
- Research and Development
- Product Development Activities
For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/gc3qvt/pulmonary?w=4
